NDC 0338-0080 – Doxorubicin Hydrochloride Liposome
Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Intravenous
Product NDC0338-0080
Product details
- Brand name
- Doxorubicin Hydrochloride Liposome
- Generic name
- Doxorubicin Hydrochloride Liposome
- Labeler
- Baxter Healthcare Company
- Dosage form
- Injection, Suspension, Liposomal
- Route
- Intravenous
- Marketing category
- NDA AUTHORIZED GENERIC · NDA050718
- Marketed since
- August 15, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Anthracycline Topoisomerase Inhibitor
Active ingredients
- Doxorubicin Hydrochloride 2 mg/mL
Uses, dosage, side effects and warnings for Doxorubicin Hydrochloride Liposome →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0338-0080-01 | 1 VIAL, SINGLE-USE in 1 CARTON (0338-0080-01) / 10 mL in 1 VIAL, SINGLE-USE | Aug 15, 2019 |